• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prolonged hematological remission by mitoxantrone and interferon--alpha-2b in a child with resistant Philadelphia chromosome-positive chronic myelogenous leukemia.

作者信息

Duru F, Tuncer M, Hiçsönmez G

出版信息

Eur J Haematol. 1993 Sep;51(3):173-4. doi: 10.1111/j.1600-0609.1993.tb00620.x.

DOI:10.1111/j.1600-0609.1993.tb00620.x
PMID:8405332
Abstract
摘要

相似文献

1
Prolonged hematological remission by mitoxantrone and interferon--alpha-2b in a child with resistant Philadelphia chromosome-positive chronic myelogenous leukemia.
Eur J Haematol. 1993 Sep;51(3):173-4. doi: 10.1111/j.1600-0609.1993.tb00620.x.
2
Complete cytogenetic and molecular remission in a case of lymphoid blast crisis in chronic myeloid leukemia with intensive chemotherapy and interferon alpha.慢性髓性白血病淋巴母细胞危象患者经强化化疗联合α干扰素治疗后实现完全细胞遗传学和分子学缓解
Eur J Haematol. 1993 Aug;51(2):122-3. doi: 10.1111/j.1600-0609.1993.tb01605.x.
3
Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon alpha-2b alone or in combination with interferon gamma.接受重组干扰素α-2b单独或联合干扰素γ长期治疗的慢性粒细胞白血病患者的微小残留病
Blood. 1991 Nov 1;78(9):2188-93.
4
Initial cytoreduction by mitoxantrone and cytarabine has no impact on the outcome of interferon-alfa-2b therapy in chronic myelogenous leukemia.米托蒽醌和阿糖胞苷进行的初始细胞减灭术对慢性粒细胞白血病患者α-干扰素-2b治疗的疗效没有影响。
Eur J Haematol. 1992 Aug;49(2):67-70. doi: 10.1111/j.1600-0609.1992.tb00033.x.
5
Tetrasomy of Philadelphia chromosome in myeloblastic crisis of chronic myelogenous leukemia.
Int J Hematol. 1995 Jun;61(4):229-30.
6
Treatment with natural human interferon alpha of a CML-patient with antibodies to recombinant interferon alpha-2b.用天然人干扰素α治疗一名对重组干扰素α-2b有抗体的慢性粒细胞白血病患者。
Blut. 1988 Nov;57(5):311-5. doi: 10.1007/BF00320360.
7
A phase I/II study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia.
Blut. 1989 Jun;58(6):275-8. doi: 10.1007/BF00320165.
8
Long-term third chronic phase of chronic myelogenous leukemia maintained by interferon-alpha and methotrexate.α-干扰素和甲氨蝶呤维持慢性粒细胞白血病长期慢性期Ⅲ期
Leuk Lymphoma. 1999 Mar;33(1-2):193-7. doi: 10.3109/10428199909093742.
9
Long-term follow-up results of alpha interferon therapy in chronic myelogenous leukemia at M. D. Anderson Cancer Center.MD安德森癌症中心慢性粒细胞白血病α干扰素治疗的长期随访结果
Leuk Lymphoma. 1993;11 Suppl 1:169-74. doi: 10.3109/10428199309047881.
10
Combined therapy interferon and chemotherapy in chronic myelogenous leukemia.
Nouv Rev Fr Hematol (1978). 1989;31(2):171-3.